A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Genentech, Inc.
Study ID
NCT00097188
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This is a Phase II, randomized, double-blind, parallel group, placebo controlled, multicenter study to evaluate the safety and efficacy of Rituximab in adults with RRMS.

Key Dates

Start date
Dec 31, 2004
Status verified
Feb 2014
Completion
Dec 31, 2006

Study Design

Enrollment
104 participants (actual)
Primary purpose
TREATMENT

Primary Outcome Measure

To investigate the efficacy of rituximab compared with placebo, as measured by MRI scans of the brain for the total number of lesions observed, and to evaluate the safety and tolerability of rituximab in subjects with RRMS.

Locations (31)

FacilityCityStateZIPSite coordinators
Phoenix Neurological AssociatesPhoenixArizona85006-
Loma Linda UniversityLoma LindaCalifornia92354-
Sutter Gould Medical FoundationModestoCalifornia95355-
University Of California At DavisSacramentoCalifornia95817-
Neurological Research Institute Of East BayWalnut CreekCalifornia94596-
Neurology Associates, P.A.MaitlandFlorida32751-
Multiple Sclerosis Center of BrevardMelbourneFlorida32940-
Neurological Services Of OrlandoOrlandoFlorida32806-
Neurological AssociatesPompano BeachFlorida33060-
MS Center of Vero BeachVero BeachFlorida32960-
MS Center Of AtlantaAtlantaGeorgia30327-
Medical College of GeorgiaAugustaGeorgia30912-
University Of Kansas Medical CenterKansas CityKansas66160-
Kentucky Neuroscience ResearchLouisvilleKentucky40202-
University of Maryland Hospital MS CenterBaltimoreMaryland21201-
Michigan Institute For Neurological DisordersFarmington HillsMichigan48334-
Deaconess Billings Clinical Research DivisionBillingsMontana59101-
Albany Medical CenterAlbanyNew York12208-
Meritcare Neuroscience ClinicFargoNorth Dakota58103-
Neurology and Neuroscience Assoc.,INCAkronOhio44302-
The Cleveland Clinic FoundationClevelandOhio44195-
The Ohio State UniversityColumbusOhio43221-
Geisinger Medical CenterDanvillePennsylvania17822-
University Of Pennsylvania Medical CenterPhiladelphiaPennsylvania19104-
Neurology Specialists of Dallas, PADallasTexas75231-
Maxine Mesinger MS Clinic/ Baylor College of MedicineHoustonTexas77030-
Neurology Clinic of San AntonioSan AntonioTexas78229-
Virginia Mason Medical CenterSeattleWashington98101-
Holy Family MS CenterSpokaneWashington99208-
Neurology and Neurosurgery Associates of Tacoma, Inc., P.S.TacomaWashington98405-
St. Luke's Medical Center/Center for Neurological DisordersMilwaukeeWisconsin53215-

Find similar trials in Phoenix, AZ

By condition
Multiple sclerosis
By specialty
NeurologyBrain disordersAutoimmune disease
By research site
Phoenix Neurological Associates· Phoenix, AZLoma Linda University· Loma Linda, CASutter Gould Medical Foundation· Modesto, CAUniversity Of California At Davis· Sacramento, CANeurological Research Institute Of East Bay· Walnut Creek, CANeurology Associates, P.A.· Maitland, FL

Related Studies